clinicaltrialsarena2d
Inhalon launches human challenge trial for RSV treatment
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
Managed Healthcare Executive13d
A Look at Human Metapneumovirus — a Respiratory Virus You've Likely Had Without Knowing
Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...
Virus spreading in China raises concerns in the United States
A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.
GlobalData on MSN6d
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.
The lesser-known winter virus that is different to flu and Covid but just as dangerous
Human metapneumovirus (hMPV) has been hitting the headlines recently as one of the lesser-known winter illnesses that can ...
hVIVO wins contract for RSV drug human trial for Inhalon Biopharma
(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...
devdiscourse6d
Human Metapneumovirus Affects Young Child in Ahmedabad
A 4-year-old boy in Ahmedabad has been diagnosed with human metapneumovirus, increasing Gujarat's cases to eight. The child is in stable condition. The virus, spreading since 2001, resembles the ...
ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research
ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defense immune enhancers to minimize the impact of respiratory viral infections in at-risk populations, announces ...